Degraded products generated by iron stent inhibit the vascular smooth muscle cell proliferation by downregulating AP-1
Abstract In-stent restenosis (ISR) following interventional therapy is a fatal clinical complication. Current evidence indicates that neointimal hyperplasia driven by uncontrolled proliferation of vascular smooth muscle cells (VSMC) is a major cause of restenosis. This implies that inhibiting VSMC p...
Saved in:
Main Authors: | Jiabing Huang, Bingjian Liu, Chunguang Zhao, Jing Li, Dongxu Qiu |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2025-01-01
|
Series: | Journal of Materials Science: Materials in Medicine |
Online Access: | https://doi.org/10.1007/s10856-024-06854-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leptin Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by Angiotensin II through Nitric Oxide-Dependent Mechanisms
by: Amaia Rodríguez, et al.
Published: (2010-01-01) -
Virgin and photo-degraded microplastics induce the activation of human vascular smooth muscle cells
by: Elisa Persiani, et al.
Published: (2025-02-01) -
Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
by: Giovanni Anfossi, et al.
Published: (2010-01-01) -
Alteration of Mevalonate Pathway in Proliferated Vascular Smooth Muscle from Diabetic Mice: Possible Role in High-Glucose-Induced Atherogenic Process
by: Guo-Ping Chen, et al.
Published: (2015-01-01) -
Geranylgeranyl Transferase-I Knockout Inhibits Oxidative Injury of Vascular Smooth Muscle Cells and Attenuates Diabetes-Accelerated Atherosclerosis
by: Guo-Ping Chen, et al.
Published: (2020-01-01)